S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma

NCT00006721 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

571

Enrollment

NETWORK

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: rituximab
DRUG: cyclophosphamide
DRUG: doxorubicin
DRUG: prednisone
DRUG: vincristine
RADIATION: tositumomab

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]
[object Object]
[object Object]